CN116445594A - Sequencing method suitable for in-situ detection of continuous multiple nucleotide sites and application thereof - Google Patents
Sequencing method suitable for in-situ detection of continuous multiple nucleotide sites and application thereof Download PDFInfo
- Publication number
- CN116445594A CN116445594A CN202310290116.2A CN202310290116A CN116445594A CN 116445594 A CN116445594 A CN 116445594A CN 202310290116 A CN202310290116 A CN 202310290116A CN 116445594 A CN116445594 A CN 116445594A
- Authority
- CN
- China
- Prior art keywords
- sequence
- sequencing
- probe
- semi
- situ
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012163 sequencing technique Methods 0.000 title claims abstract description 105
- 238000011065 in-situ storage Methods 0.000 title claims abstract description 50
- 238000001514 detection method Methods 0.000 title claims abstract description 28
- 239000002773 nucleotide Substances 0.000 title claims abstract description 18
- 125000003729 nucleotide group Chemical group 0.000 title claims abstract description 18
- 239000000523 sample Substances 0.000 claims abstract description 131
- 238000000034 method Methods 0.000 claims abstract description 35
- 230000035772 mutation Effects 0.000 claims abstract description 18
- 238000013461 design Methods 0.000 claims abstract description 15
- 230000003321 amplification Effects 0.000 claims abstract description 13
- 238000003384 imaging method Methods 0.000 claims abstract description 13
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 13
- 238000005096 rolling process Methods 0.000 claims abstract description 12
- 102000003960 Ligases Human genes 0.000 claims abstract description 9
- 108090000364 Ligases Proteins 0.000 claims abstract description 9
- 238000006243 chemical reaction Methods 0.000 claims description 46
- 239000012634 fragment Substances 0.000 claims description 28
- 238000009396 hybridization Methods 0.000 claims description 28
- 230000000295 complement effect Effects 0.000 claims description 22
- 108020004414 DNA Proteins 0.000 claims description 20
- 102000053602 DNA Human genes 0.000 claims description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 229930040373 Paraformaldehyde Natural products 0.000 claims description 8
- 229920002866 paraformaldehyde Polymers 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 7
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 claims description 5
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 claims description 5
- 230000009471 action Effects 0.000 claims description 5
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 238000011534 incubation Methods 0.000 claims description 2
- 238000007169 ligase reaction Methods 0.000 claims description 2
- 230000026731 phosphorylation Effects 0.000 claims description 2
- 238000006366 phosphorylation reaction Methods 0.000 claims description 2
- 230000008685 targeting Effects 0.000 claims 4
- 230000000977 initiatory effect Effects 0.000 claims 3
- 230000000865 phosphorylative effect Effects 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 150000007523 nucleic acids Chemical group 0.000 abstract description 5
- 206010028980 Neoplasm Diseases 0.000 abstract description 4
- 238000011161 development Methods 0.000 abstract description 3
- 238000010276 construction Methods 0.000 abstract description 2
- 108090000623 proteins and genes Proteins 0.000 abstract description 2
- 238000012214 genetic breeding Methods 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 238000001228 spectrum Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 33
- 108020004999 messenger RNA Proteins 0.000 description 21
- 238000005516 engineering process Methods 0.000 description 13
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 12
- 239000007788 liquid Substances 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
- 238000003559 RNA-seq method Methods 0.000 description 7
- 230000037452 priming Effects 0.000 description 7
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000014509 gene expression Effects 0.000 description 6
- 238000010226 confocal imaging Methods 0.000 description 4
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical group NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
- 238000012217 deletion Methods 0.000 description 4
- 230000037430 deletion Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical group O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000012174 single-cell RNA sequencing Methods 0.000 description 4
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
- 108020004682 Single-Stranded DNA Proteins 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000012149 elution buffer Substances 0.000 description 3
- 229940097275 indigo Drugs 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 108010085238 Actins Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 2
- 238000000636 Northern blotting Methods 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 229940104302 cytosine Drugs 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 230000009274 differential gene expression Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000007481 next generation sequencing Methods 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
- C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明公开了一种适用于原位检测连续多个核苷酸位点的测序方法及其应用,该方法通过设计捕获靶向区域的半闭合锁式探针,通过连接酶填补探针上的空缺,经滚环扩增实现对待检未知序列的测序,多轮连接测序可解析X个待检碱基。依据其探针设计特点,可对未知核酸序列测序,能应用于肿瘤点突变检测、连续突变检测等。可实现单细胞、单分子、单碱基分辨率的基因序列原位解读。该方法可进行高通量组织原位检测,获得组织样本不同细胞的目标序列的原位空间谱图,无需进行高难度的体外寡量特异性细胞富集建库测序。且信号解读不依赖于超分辨成像平台,在个体发育、遗传育种、肿瘤微环境及临床病理检测等领域均有较好的应用前景。
The invention discloses a sequencing method suitable for in situ detection of multiple consecutive nucleotide sites and its application. The method designs a semi-closed locking probe that captures the target region, and fills in the gaps on the probe with ligase. Vacancies, the sequencing of the unknown sequence to be detected is realized by rolling circle amplification, and X number of bases to be detected can be resolved by multiple rounds of ligation sequencing. According to its probe design characteristics, it can sequence unknown nucleic acid sequences, and can be applied to tumor point mutation detection, continuous mutation detection, etc. It can realize in situ interpretation of gene sequences with single-cell, single-molecule, and single-base resolution. This method can perform high-throughput tissue in situ detection, and obtain in situ spatial spectra of target sequences in different cells of tissue samples, without the need for difficult in vitro oligo-specific cell enrichment library construction and sequencing. Moreover, the signal interpretation does not depend on the super-resolution imaging platform, and has good application prospects in the fields of individual development, genetic breeding, tumor microenvironment, and clinical pathological detection.
Description
技术领域technical field
本发明涉及原位测序领域,具体涉及一种适用于原位检测连续多个核苷酸位点的测序方法及其应用。The invention relates to the field of in situ sequencing, in particular to a sequencing method suitable for in situ detection of multiple consecutive nucleotide sites and its application.
背景技术Background technique
细胞是生物体结构和功能的基本单位。自1839年细胞学说建立后,无数科学家致力于研究细胞的解构、功能及彼此间的关系等,以期探明生命的本质。1958年,沃森和克里克提出中心法则,阐述了遗传信息在生物大分子之间传递的顺序,分子生物学时代就此拉开序幕。在此基础上,基因组学、转录组学、蛋白组学等现代生物学科蓬勃发展,科学家们在探寻生命活动奥秘研究上扬帆起航。其中,mRNA由DNA转录而来,在核糖体的协助下合成蛋白质,是遗信息的传递者,蛋白质翻译的蓝图,在生命活动中起着至关重要的作用。迄今,全世界有数以万计的科研人员致力于mRNA的研究。Cells are the basic units of structure and function in living organisms. Since the establishment of the cell theory in 1839, countless scientists have devoted themselves to studying the deconstruction, function and relationship between cells, in order to ascertain the essence of life. In 1958, Watson and Crick put forward the central dogma, explaining the order in which genetic information is transmitted between biological macromolecules, and the era of molecular biology kicked off. On this basis, modern biology disciplines such as genomics, transcriptomics, and proteomics are flourishing, and scientists are setting sail to explore the mysteries of life activities. Among them, mRNA is transcribed from DNA and synthesizes protein with the assistance of ribosomes. It is the carrier of genetic information, the blueprint of protein translation, and plays a vital role in life activities. So far, tens of thousands of researchers around the world are devoted to the research of mRNA.
技术变革是推动研究发展的根本。早期对mRNA的研究受制于实验技术,需要先从细胞或组织中提取出mRNA,再通过Northern印迹杂交法(Northern blot)、荧光定量聚合酶链式反应(quantitative real time PCR,qPCR)、第一代测序技术等来研究。此类方法费时费力,能获取的信息也很有限。随着二代测序技术的推广,科学家们逐步实现了对mRNA的大规模并行测序,开发出一系列的RNA测序技术(RNA-seq)。在过去的十年中,RNA-seq已经成为在全转录组范围内分析差异基因表达和mRNA差异剪接的重要工具,包括单细胞基因表达、翻译和RNA结构等。Technological change is fundamental to promote the development of research. The early research on mRNA was restricted by experimental techniques. It was necessary to extract mRNA from cells or tissues first, and then through Northern blot hybridization (Northern blot), fluorescent quantitative real time PCR (qPCR), the first Generational sequencing technology, etc. to study. Such methods are time-consuming and laborious, and the information that can be obtained is also very limited. With the promotion of next-generation sequencing technology, scientists have gradually realized large-scale parallel sequencing of mRNA and developed a series of RNA sequencing technologies (RNA-seq). Over the past decade, RNA-seq has emerged as an important tool for transcriptome-wide analysis of differential gene expression and differential mRNA splicing, including single-cell gene expression, translation, and RNA structure.
传统的RNA测序(如bulk RNA-seq)是将一整块组织中的RNA提取出来进行建库、测序,获得此区域内各种细胞转录本的平均表达水平。但组织中不同细胞发挥的功能不同,mRNA表达水平也有差异,常规RNA-seq的均一化策略会掩盖掉许多重要信息。为了探寻组织中不同细胞的特点和功能,2009年,汤富酬教授基于前人技术进行改良,形成了第一个的真正意义的单细胞RNA测序技术(single cell RNAsequencing,scRNA-seq)。Traditional RNA sequencing (such as bulk RNA-seq) is to extract RNA from a whole tissue for library construction and sequencing to obtain the average expression level of various cell transcripts in this region. However, different cells in tissues have different functions and mRNA expression levels are also different. The normalization strategy of conventional RNA-seq will cover up many important information. In order to explore the characteristics and functions of different cells in tissues, in 2009, Professor Tang Fuchou improved based on the previous technology and formed the first real single cell RNA sequencing technology (single cell RNA sequencing, scRNA-seq).
2013年,Nature Method将年度技术授予单细胞测序。该技术能够提供每个细胞的RNA表达谱,并鉴定异质细胞群中的稀有细胞,极大推动了发育生物学、神经生物学、癌症机理等方面的研究。scRNA-seq方法和bulk RNA-seq技术共同发挥功能,为研究者们提供了关于组织或细胞群体的高度详细的数据,提高了人们对组织内细胞的身份信息和状态的认知。然而,此类方法共同的缺点是失去了mRNA在细胞中的空间信息。这类信息非常重要,因为特定的细胞类型及组织与生命活动密切相关。In 2013, Nature Method awarded Technology of the Year to single-cell sequencing. This technology can provide the RNA expression profile of each cell and identify rare cells in heterogeneous cell populations, which greatly promotes the research of developmental biology, neurobiology, cancer mechanism and so on. The scRNA-seq method and bulk RNA-seq technology work together to provide researchers with highly detailed data about a tissue or cell population, improving people's understanding of the identity and status of cells within the tissue. However, the common disadvantage of such methods is the loss of spatial information of mRNA in cells. This type of information is important because specific cell types and tissues are closely related to life activities.
为了对转录本的空间信息进行研究,以分析细胞环境与基因表达之间的密切关系,科学家们提出空间转录组学(spatial transcriptomics,ST)。其中,基于成像的RNA原位测序方法(in situ sequencing,ISS),可以直接对处于组织环境中的细胞中的mRNA进行测序,这样既能得到单个细胞特定转录本的具体序列,还能得到其空间位置和对应的表达水平,能将获得的mRNA信息标定到它真实的地方,是相对理想的方式。In order to study the spatial information of transcripts and analyze the close relationship between cell environment and gene expression, scientists proposed spatial transcriptomics (spatial transcriptomics, ST). Among them, the imaging-based RNA in situ sequencing method (in situ sequencing, ISS) can directly sequence the mRNA in cells in the tissue environment, so that not only the specific sequence of a specific transcript of a single cell can be obtained, but also its The spatial position and the corresponding expression level can be used to calibrate the obtained mRNA information to its real place, which is a relatively ideal way.
目前,常用的mRNA原位测序根据其捕获转录本的方法可分为两类:Currently, commonly used mRNA in situ sequencing can be divided into two categories according to the method used to capture transcripts:
1)一类是非靶向捕获转录本的方法,代表技术有FISSEQ、INSTA-Seq。此类方法理论上能对捕获所有转录本,检测细胞内所有转录本的信息,但实际中此类技术特异性较差,获得的数据中rRNA信号较多,mRNA的检测效率较低,且往往步骤较繁琐,目前应用不多。1) One category is the method of non-targeted capture of transcripts, representative technologies include FISSEQ and INSTA-Seq. This type of method can theoretically capture all transcripts and detect the information of all transcripts in the cell, but in practice this type of technology has poor specificity, there are more rRNA signals in the obtained data, and the detection efficiency of mRNA is low, and often The steps are cumbersome, and there are not many applications at present.
2)另一类方法为靶向捕获转录本的方法,代表技术为STARmap(Spatially-resolved Transcript Amplicon Readout Mapping)。该类方法通常依赖锁式探针(padlock probe),用此种探针对某一特定转录本进行原位捕获,此类方法通常较为灵敏、特异,但测序通量较低,一条锁式探针只能检测一个位点的一种突变,想要进行稍长的测序就需设计多条探针,操作繁琐且成本较高。2) Another method is the method of targeted capture of transcripts, and the representative technology is STARmap (Spatially-resolved Transcript Amplicon Readout Mapping). This type of method usually relies on a padlock probe, which is used to capture a specific transcript in situ. This type of method is usually more sensitive and specific, but the sequencing throughput is low. A padlock probe The needle can only detect one mutation at one site, and it is necessary to design multiple probes for slightly longer sequencing, which is cumbersome and costly.
如图1所示:经典锁式探针在进行原位测序时,一旦待测序列上存在突变,则需要基于先验的知识设计并合成多种探针。当待测位点存在一个点突变时,因突变结果可能是A\T\C\G其中任意一种,需要分别合成出对应的探针,至少有4种,还需要知道突变碱基的具体位置,才能用经典的锁式探针捕获。一旦存在连续几个突变,甚至是多种突变同时出现,就需要设计大量的探针来检测。一次实验使用多种经典探针,不仅大大增加了成本,还会降低杂交效率、增加非特异性。As shown in Figure 1: when performing in situ sequencing with classical padlock probes, once there is a mutation in the sequence to be tested, it is necessary to design and synthesize a variety of probes based on prior knowledge. When there is a point mutation at the site to be tested, because the mutation result may be any of A\T\C\G, it is necessary to synthesize corresponding probes, at least 4 kinds, and it is also necessary to know the specificity of the mutated base position to be captured with a classic padlock probe. Once there are several consecutive mutations, or even multiple mutations appearing at the same time, it is necessary to design a large number of probes for detection. Using a variety of classical probes in one experiment not only greatly increases the cost, but also reduces hybridization efficiency and increases non-specificity.
如何直接、靶向且简单地对核酸进行原位测序,是目前技术开发的当务之急。How to directly, targeted and simply perform in situ sequencing of nucleic acids is a top priority for current technology development.
发明内容Contents of the invention
本发明的目的在于克服现有技术的不足,提供了一种适用于原位检测连续多个核苷酸位点的测序方法及其应用,本发明使用半闭合的锁式探针,特异性杂交目的核酸,通过连接的方式,将一段单链随机脱氧核糖核苷酸填补进锁式探针形成的Gap中,形成完整的环状结构,通过滚环扩增的方式原位放大捕获的信息,再通过连接测序对Gap中对应的序列进行解读,最后进行图像分析获得转录本的空间信息。该方法仅需4轮连接测序,即可测得核酸上连续4个碱基的序列。使用普通锁式探针,测得4个碱基序列需设置44=256条探针,本方法仅需1条,大大减少了探针设计工作量和制备的成本。本发明可以直接原位测序RNA,无需将其反转录为cDNA,且保留了空间信息,减少操作步骤的同时提高了检测效率。该方法可检测一段未知序列,无需先验知识,特异性强,容错率高。The purpose of the present invention is to overcome the deficiencies of the prior art, and to provide a sequencing method suitable for in situ detection of multiple nucleotide sites and its application. The present invention uses a semi-closed padlock probe for specific hybridization The target nucleic acid is filled with a single-stranded random deoxyribonucleotide into the gap formed by the padlock probe by ligation to form a complete circular structure, and the captured information is amplified in situ by rolling circle amplification. Then, the corresponding sequence in the Gap was interpreted by ligation sequencing, and finally the image analysis was performed to obtain the spatial information of the transcript. This method only needs 4 rounds of ligation sequencing to measure the sequence of 4 consecutive bases on the nucleic acid. Using ordinary padlock probes, 4 4 =256 probes are required to measure 4 base sequences, but only one probe is required in this method, which greatly reduces the workload of probe design and the cost of preparation. The invention can directly sequence the RNA in situ without reverse transcribing it into cDNA, and retains the spatial information, reduces the operation steps and improves the detection efficiency. The method can detect an unknown sequence without prior knowledge, and has strong specificity and high error tolerance.
为实现上述目的,本发明所设计的技术方案如下:In order to achieve the above object, the technical scheme designed by the present invention is as follows:
本发明提供了一种适用于原位检测连续多个核苷酸位点的测序方法,包括以下步骤:The present invention provides a sequencing method suitable for in situ detection of multiple consecutive nucleotide sites, comprising the following steps:
1)探针的设计1) Design of the probe
根据待检序列筛选出杂交效率高、特异性好、无高级结构的靶向区域,设置杂交探针;其中,所述的杂交探针包括半闭合锁式探针和RCA引发探针;According to the sequence to be detected, a target region with high hybridization efficiency, good specificity, and no advanced structure is screened out, and hybridization probes are set; wherein, the hybridization probes include semi-closed lock probes and RCA priming probes;
所述半闭合锁式探针与待检序列的靶向序列互补后会在半闭合锁式探针5’和3’端间形成空缺,After the half-closed lock probe is complementary to the target sequence of the sequence to be detected, a gap will be formed between the 5' and 3' ends of the half-closed lock probe,
所述空缺由X个碱基的单链脱氧核糖核酸随机片段(5’-NNNN-3’)填补并与待检序列的靶向序列(即为测序目标)互补;其中,X为2、3、4、5、6、7、8……;The gap is filled by a random fragment of single-stranded DNA of X bases (5'-NNNN-3') and is complementary to the target sequence of the sequence to be detected (ie, the sequencing target); wherein, X is 2, 3 , 4, 5, 6, 7, 8...;
2)探针预处理2) Probe pretreatment
对杂交探针中的半闭合锁式探针、X个碱基的单链脱氧核糖核酸随机片段的5’端进行磷酸化;Phosphorylate the 5' end of the semi-closed padlock probe, a random fragment of single-stranded deoxyribose nucleic acid of X bases in the hybridization probe;
3)样品杂交3) Sample hybridization
在待测样本上制备一个反应腔室,用4%的多聚甲醛(PFA)对样本进行固定,然后用甲醇脱水和变性,再将含有杂交探针的体系加入其中孵育一段时间;Prepare a reaction chamber on the sample to be tested, fix the sample with 4% paraformaldehyde (PFA), then dehydrate and denature it with methanol, then add the system containing the hybridization probe into it and incubate for a period of time;
4)连接反应4) Ligation reaction
将含有X个碱基的单链脱氧核糖核酸随机片段的连接体系加入到反应腔室中,使与待检序列互补配对的半闭合锁式探针上的空缺(Gap)被填补,形成闭合的环状结构;Add the ligation system of random fragments of single-stranded deoxyribonucleic acid containing X bases into the reaction chamber, so that the gap (Gap) on the semi-closed locking probe that is complementary to the sequence to be detected is filled to form a closed ring structure;
5)滚环扩增5) Rolling circle amplification
RCA引发探针同时与待检序列的靶向序列和半闭合锁式探针互补,在Phi29 DNA聚合酶的作用下,以RCA引发探针为引物,半闭合锁式探针形成的环状结构为模板,进行滚环扩增,将目标信号放大;The RCA priming probe is complementary to the target sequence of the sequence to be detected and the semi-closed lock probe at the same time. Under the action of Phi29 DNA polymerase, the RCA priming probe is used as a primer, and the semi-closed lock probe forms a circular structure As a template, rolling circle amplification is performed to amplify the target signal;
6)对靶序列原位测序(应用连接测序的原理)6) Sequencing the target sequence in situ (applying the principle of ligation sequencing)
Ⅰ.原位测序Ⅰ. In situ sequencing
将含有锚定引物和测序引物的测序体系加入反应腔室中进行原位测序反应,对半闭合锁式探针之间的空缺(Gap)中第一位碱基对应的序列进行测序成像,解读靶向序列的空间位置及序列信息;Add the sequencing system containing anchor primers and sequencing primers into the reaction chamber for in situ sequencing reaction, sequence and image the sequence corresponding to the first base in the gap (Gap) between semi-closed probes, and interpret The spatial position and sequence information of the target sequence;
Ⅱ.同法依次解读半闭合锁式探针之间的空缺(Gap)中其它位置碱基序列的信息;Ⅱ. Interpret the base sequence information at other positions in the gap (Gap) between the half-closed padlock probes sequentially in the same way;
Ⅲ.对上述获得的多轮测序信息进行匹配,解读半闭合锁式探针之间形成空缺(Gap)对应的靶向序列。III. Match the multiple rounds of sequencing information obtained above, and interpret the target sequence corresponding to the gap (Gap) formed between the half-closed probes.
进一步地,所述步骤1)中,待检序列的靶向序列由4段连续的靶序列A、D、B和C组成,所述半闭合锁式探针由5’端至3端’为A’序列,loop序列和B’序列,Further, in the step 1), the target sequence of the sequence to be detected is composed of 4 consecutive target sequences A, D, B and C, and the semi-closed lock probe is from the 5' end to the 3 end'. A' sequence, loop sequence and B' sequence,
所述A’序列和B’序列分别与靶序列A、靶序列B互补,所述半闭合锁式探针与靶序列互补配对后形成半闭合的环状结构;所述loop序列分别由anchor序列和barcode序列组成;The A' sequence and the B' sequence are complementary to the target sequence A and the target sequence B respectively, and the semi-closed lock probe forms a semi-closed loop structure after complementary pairing with the target sequence; the loop sequence consists of an anchor sequence Composed of barcode sequences;
所述空缺的序列D’与靶序列D互补。The vacant sequence D' is complementary to the target sequence D.
再进一步地,所述步骤1)中,所述空缺的序列D’由Y段序列组成,所述Y小于X且Y为1、2、3、4、5、6、7、8……(即:X=x 1+x 2+……+x Y,X为空缺中所有碱基的数量,Y为组成空缺中随机序列的段数,x为每段序列中碱基的数量)。Still further, in the step 1), the vacant sequence D' is composed of a sequence Y, wherein Y is less than X and Y is 1, 2, 3, 4, 5, 6, 7, 8...( That is: X=x 1 +x 2 +...+x Y , X is the number of all bases in the gap, Y is the number of segments forming the random sequence in the gap, and x is the number of bases in each sequence).
再进一步地,所述空缺的序列D’中,X为2~8个,Y为1~6。Still further, in the vacant sequence D', X is 2-8, and Y is 1-6.
再进一步地,所述步骤1)中,X为4个(所述空缺的序列D’由4个碱基的单链脱氧核糖核酸随机片段组成),Y为1个。Still further, in the step 1), X is 4 (the sequence D' of the vacancy is composed of random fragments of single-stranded deoxyribonucleic acid of 4 bases), and Y is 1.
再进一步地,所述步骤2)中,对单链脱氧核糖核酸随机片段的5’端进行磷酸化。Further, in the step 2), the 5' end of the random fragment of single-stranded deoxyribose nucleic acid is phosphorylated.
再进一步地,所述步骤2)中,磷酸化处理过程中,使用的酶为T4多聚核苷酸激酶(PNK)。Still further, in the step 2), during the phosphorylation treatment, the enzyme used is T4 polynucleotide kinase (PNK).
再进一步地,所述步骤4)中,连接酶反应体系的连接酶为Splint R连接酶。Still further, in the step 4), the ligase of the ligase reaction system is Splint R ligase.
再进一步地,所述步骤6)中,对靶序列原位测序Further, in the step 6), the target sequence is sequenced in situ
Ⅰ.原位测序Ⅰ. In situ sequencing
将含有锚定引物和测序引物的测序体系加入反应腔室中进行原位测序反应,对半闭合锁式探针之间的空缺(Gap)中第一位碱基对应的序列进行测序成像,解读靶向序列的数量、空间位置及序列信息;Add the sequencing system containing anchor primers and sequencing primers into the reaction chamber for in situ sequencing reaction, sequence and image the sequence corresponding to the first base in the gap (Gap) between semi-closed probes, and interpret The number, spatial location and sequence information of the target sequence;
Ⅱ.同法依次解读半闭合锁式探针之间的空缺(Gap)中第二位、第三位、第四位碱基序列的信息;Ⅱ. Interpret the information of the second, third, and fourth base sequences in the gaps (Gap) between semi-closed locked probes in the same way;
Ⅲ.对上述获得的四轮测序信息进行匹配,解读半闭合锁式探针之间形成空缺(Gap)对应的靶向序列。III. Match the four rounds of sequencing information obtained above, and interpret the target sequence corresponding to the gap (Gap) formed between the semi-closed probes.
本发明还提供了一种上所述的适用于原位检测连续多个核苷酸位点的测序方法在点突变检测中的应用。The present invention also provides an application of the above-mentioned sequencing method suitable for in situ detection of multiple consecutive nucleotide sites in the detection of point mutations.
本发明的原理:Principle of the present invention:
本发明中,半闭合锁式探针与待检序列的靶向序列互补后会在半闭合锁式探针5’和3’端间形成空缺,In the present invention, after the half-closed lock probe is complementary to the target sequence of the sequence to be detected, a gap will be formed between the 5' and 3' ends of the half-closed lock probe,
该空缺可以被X个碱基长的单链脱氧核糖核酸随机片段填补,连接锁式探针形成完整的环状结构。该过程依赖于连接酶对随机片段5’及3’端碱基与靶序列精准互补配对的识别,任意一端不匹配则无法被连接酶连接形成闭环。同时,随机片段中间部分和靶序列不完全匹配时,由于杂交形成的氢键作用力较弱,随机片段很容易从靶序列上解离下来。只有完全互补配对的片段才能稳定填补进空缺(Gap)内,并被连接酶连接到锁式探针上。靶序列包括但不局限于DNA或者RNA。The vacancy can be filled by random fragments of single-stranded deoxyribonucleic acid of X base length, and connected with padlock probes to form a complete circular structure. This process relies on the ligase to recognize the precise complementary pairing of the bases at the 5' and 3' ends of the random fragments and the target sequence. If any end does not match, it cannot be ligated by the ligase to form a closed loop. At the same time, when the middle part of the random fragment does not completely match the target sequence, the random fragment is easily dissociated from the target sequence due to the weak hydrogen bond force formed by hybridization. Only fragments that are completely complementary can be stably filled into the gap (Gap) and connected to the padlock probe by ligase. Target sequences include, but are not limited to, DNA or RNA.
本发明的有益效果:Beneficial effects of the present invention:
1.特异性高:本发明使用半闭合的锁式探针捕获特异的转录本,且使用单链脱氧核糖核酸随机片段填补Gap,其信号扩增取决于两部分:锁式探针捕获区同靶序列的精准互补配对,以及随机片段的精准填补。只有同时满足上述条件的目标片段才能最终被检测到,提高了方法特异性。1. High specificity: The present invention uses a semi-closed padlock probe to capture specific transcripts, and uses random fragments of single-stranded DNA to fill in the Gap, and its signal amplification depends on two parts: the padlock probe capture area is the same as Precise complementary pairing of target sequences, and precise filling of random fragments. Only target fragments that meet the above conditions at the same time can be finally detected, which improves the specificity of the method.
2.探针设计简单,成本低。传统原位测序技术要测得连续4个碱基序列,需设置44=256条探针,本发明仅需1条锁式探针,配合4碱基单链脱氧核糖核酸随机片段,即可测得RNA上连续4个碱基的序列。探针设计简化,且极大缩减了成本。2. The probe is simple in design and low in cost. Traditional in situ sequencing technology requires 4 4 = 256 probes to measure consecutive 4 base sequences. The present invention only needs 1 padlock probe, combined with random fragments of 4-base single-stranded deoxyribonucleic acid. Measure the sequence of 4 consecutive bases on the RNA. The probe design is simplified and the cost is greatly reduced.
3.可用于检测基因突变。本发明可针对序列上存在的点突变,或者一定长度的连续突变进行直接测序,在肿瘤突变检测中具有较好的应用前景。对于单个位点的缺失突变本发明也可检,比如:使用预期形成4个碱基的Gap的锁式探针检测某个可能存在缺失突变的位点,在连接体系中额外加入3碱基单链脱氧核糖核酸随机片段,如若发生缺失突变,则此锁式探针形成3碱基Gap,也能被填补上,通过后续测序即可得知缺失突变的信息。3. It can be used to detect gene mutations. The present invention can directly sequence point mutations or continuous mutations of a certain length on the sequence, and has good application prospects in tumor mutation detection. The present invention can also detect the deletion mutation of a single site, for example: use a padlock probe that is expected to form a Gap of 4 bases to detect a site that may have a deletion mutation, and add an additional 3 bases to the connection system If a deletion mutation occurs in a random fragment of strand deoxyribonucleic acid, the padlock probe forms a 3-base gap, which can also be filled in, and the information of the deletion mutation can be obtained through subsequent sequencing.
4.该方法可直接检测一段未知序列的核酸,设计探针时只需要知道其两侧片段即可。4. This method can directly detect a nucleic acid with an unknown sequence, and only need to know the fragments on both sides when designing the probe.
5.成像条件普适性高:共聚焦成像系统即可实现信号解读。本发明通过滚环扩增的方法放大信号,其结果亮度高,能用共聚焦成像系统检出。5. High universality of imaging conditions: the confocal imaging system can realize signal interpretation. The invention amplifies the signal through the method of rolling circle amplification, and the result has high brightness and can be detected by a confocal imaging system.
6.本发明可实现单细胞水平上的原位测序。6. The present invention can realize in situ sequencing at the single cell level.
7.本发明直接靶向mRNA,无需将其反转录为cDNA,能提高准确度,节省成本,操作简便。7. The present invention directly targets mRNA without reverse transcription into cDNA, which can improve accuracy, save cost, and is easy to operate.
8.连接步骤利用SplintR酶,更加特异、高效。8. The connection step uses SplintR enzyme, which is more specific and efficient.
综上所述,本发明通过使用半闭合的锁式探针,在SplintR酶的作用下使4碱基单链脱氧核糖核酸随机片段准确填补在Gap中,形成一个完整的环状结构,再通过滚环扩增放大信号,读取测序结果。相比于传统的方法,本发明探针设计更简单,省时省力,成本低,能直接地捕获到mRNA上的序列,对于检测突变有良好的应用前景。且本发明运用共聚焦成像系统捕获信号,无需超分辨成像系统,降低了实验成本和难度,易于普及。In summary, the present invention uses a semi-closed padlock probe to accurately fill in random fragments of 4-base single-stranded deoxyribonucleic acid in the Gap under the action of the SplintR enzyme to form a complete circular structure, and then pass Rolling circle amplification amplifies the signal and reads the sequencing results. Compared with the traditional method, the probe design of the present invention is simpler, saves time and effort, and is low in cost, and can directly capture the sequence on the mRNA, and has a good application prospect for detecting mutations. Moreover, the present invention uses a confocal imaging system to capture signals without requiring a super-resolution imaging system, which reduces the cost and difficulty of experiments and is easy to popularize.
附图说明Description of drawings
图1为经典锁式探针的设计图;Figure 1 is a design diagram of a classic padlock probe;
图2为本发明的杂交探针的设计图;Fig. 2 is the design drawing of the hybridization probe of the present invention;
图3为本发明的Fill-in方法的技术流程图;Fig. 3 is the technical flowchart of the Fill-in method of the present invention;
图4为本发明的Fill-in方法的测序成像效果图;Fig. 4 is the effect diagram of sequencing imaging of the Fill-in method of the present invention;
图中,红色点代表测得的序列是鸟嘌呤G,靛青色点代表胞嘧啶C。In the figure, the red dot represents the detected sequence is guanine G, and the indigo dot represents cytosine C.
具体实施方式Detailed ways
下面结合具体实施例对本发明作进一步的详细描述,以便本领域技术人员理解。The present invention will be described in further detail below in conjunction with specific embodiments, so that those skilled in the art can understand.
本发明提供了一种适用于原位检测连续多个核苷酸位点的测序方法,包括以下步骤:The present invention provides a sequencing method suitable for in situ detection of multiple consecutive nucleotide sites, comprising the following steps:
1)探针的设计1) Design of the probe
根据待检序列筛选出杂交效率高、特异性好、无高级结构的靶向区域,设置杂交探针;其中,所述的杂交探针包括半闭合锁式探针和RCA引发探针;According to the sequence to be detected, a target region with high hybridization efficiency, good specificity, and no advanced structure is screened out, and hybridization probes are set; wherein, the hybridization probes include semi-closed lock probes and RCA priming probes;
所述半闭合锁式探针与待检序列的靶向序列互补后会在半闭合锁式探针5’和3’端间形成空缺,After the half-closed lock probe is complementary to the target sequence of the sequence to be detected, a gap will be formed between the 5' and 3' ends of the half-closed lock probe,
所述空缺由X个碱基的单链脱氧核糖核酸随机片段(5’-NNNN-3’)填补并与待检序列的靶向序列(即为测序目标)互补;其中,X为2、3、4、5、6、7、8……;The gap is filled by a random fragment of single-stranded DNA of X bases (5'-NNNN-3') and is complementary to the target sequence of the sequence to be detected (ie, the sequencing target); wherein, X is 2, 3 , 4, 5, 6, 7, 8...;
2)探针预处理2) Probe pretreatment
对杂交探针中的半闭合锁式探针、X个碱基的单链脱氧核糖核酸随机片段的5’端进行磷酸化;Phosphorylate the 5' end of the semi-closed padlock probe, a random fragment of single-stranded deoxyribose nucleic acid of X bases in the hybridization probe;
3)样品杂交3) Sample hybridization
在待测样本上制备一个反应腔室,用4%的多聚甲醛(PFA)对样本进行固定,然后用甲醇脱水和变性,再将含有杂交探针的体系加入其中孵育一段时间;Prepare a reaction chamber on the sample to be tested, fix the sample with 4% paraformaldehyde (PFA), then dehydrate and denature it with methanol, then add the system containing the hybridization probe into it and incubate for a period of time;
4)连接反应4) Ligation reaction
将含有X个碱基的单链脱氧核糖核酸随机片段的连接体系加入到反应腔室中,使与待检序列互补配对的半闭合锁式探针上的空缺(Gap)被填补,形成闭合的环状结构;Add the ligation system of random fragments of single-stranded deoxyribonucleic acid containing X bases into the reaction chamber, so that the gap (Gap) on the semi-closed locking probe that is complementary to the sequence to be detected is filled to form a closed ring structure;
5)滚环扩增5) Rolling circle amplification
RCA引发探针同时与待检序列的靶向序列和半闭合锁式探针互补,在Phi29 DNA聚合酶的作用下,以RCA引发探针为引物,半闭合锁式探针形成的环状结构为模板,进行滚环扩增,将目标信号放大;The RCA priming probe is complementary to the target sequence of the sequence to be detected and the semi-closed lock probe at the same time. Under the action of Phi29 DNA polymerase, the RCA priming probe is used as a primer, and the semi-closed lock probe forms a circular structure As a template, rolling circle amplification is performed to amplify the target signal;
6)对靶序列原位测序(应用连接测序的原理)6) Sequencing the target sequence in situ (applying the principle of ligation sequencing)
Ⅰ.原位测序Ⅰ. In situ sequencing
将含有锚定引物和测序引物的测序体系加入反应腔室中进行原位测序反应,对半闭合锁式探针之间的空缺(Gap)中第一位碱基对应的序列进行测序成像,解读靶向序列的空间位置及序列信息。Add the sequencing system containing anchor primers and sequencing primers into the reaction chamber for in situ sequencing reaction, sequence and image the sequence corresponding to the first base in the gap (Gap) between semi-closed probes, and interpret Spatial location and sequence information of the target sequence.
Ⅱ.同法依次解读半闭合锁式探针之间的空缺(Gap)中其它位置碱基序列的信息。Ⅱ. Interpret the base sequence information of other positions in the gap (Gap) between the semi-closed padlock probes sequentially in the same way.
Ⅲ.对上述获得的多轮测序信息进行匹配,解读半闭合锁式探针之间形成空缺(Gap)对应的靶向序列。III. Match the multiple rounds of sequencing information obtained above, and interpret the target sequence corresponding to the gap (Gap) formed between the half-closed probes.
基于上述方法,根据实际情况进行如下检测:Based on the above method, the following tests are carried out according to the actual situation:
实施例1Example 1
利用上述原位检测连续多个核苷酸位点的测序方法,对β-actin转录本上4个碱基长的序列进行原位测序In situ sequencing of 4-base-long sequences on β-actin transcripts using the above-mentioned sequencing method for in situ detection of consecutive multiple nucleotide sites
1.杂交探针的设计1. Design of Hybridization Probes
根据待检序列的靶向序列,筛选出杂交效率高、特异性好、无高级结构的区段,设计杂交探针,该杂交探针靶向mRNA上一段序列。表1According to the target sequence of the sequence to be detected, a segment with high hybridization efficiency, good specificity, and no advanced structure is screened out, and a hybridization probe is designed, which targets a sequence on the mRNA. Table 1
2.探针预处理2. Probe Pretreatment
应用T4多聚核苷酸激酶(PNK)对半闭合锁式探针、4碱基的单链脱氧核糖核酸随机片段的5’端进行磷酸化处理;Apply T4 polynucleotide kinase (PNK) to phosphorylate the 5' end of the semi-closed padlock probe, a random fragment of 4-base single-stranded deoxyribonucleic acid;
3.样品杂交3. Sample hybridization
①该方法在细胞样品上进行试验。要培养细胞至足够的数量进行试验,并且为方便后续操作,首先,在玻璃底培养皿中培养细胞至80%满,在实验前弃掉培养基,在玻璃底培养皿上制备一个反应腔室。PBST(含0.1% Tween-20的PBS)洗3次,去除残留培养基以及其它杂质。① This method is tested on cell samples. To culture cells to a sufficient number for experiments, and to facilitate subsequent operations, first, culture cells in a glass-bottomed Petri dish to 80% full, discard the medium before the experiment, and prepare a reaction chamber on the glass-bottomed Petri dish . Wash with PBST (PBS containing 0.1% Tween-20) 3 times to remove residual medium and other impurities.
②为了使细胞保持形态,并让其中的mRNA保持原本的空间位置,用4%多聚甲醛对细胞固定10分钟,反应完成后弃掉液体,室温下PBST洗3次,每次5分钟,除去多余的PFA。②In order to maintain the shape of the cells and keep the mRNA in the original spatial position, fix the cells with 4% paraformaldehyde for 10 minutes, discard the liquid after the reaction is completed, wash 3 times with PBST at room temperature, 5 minutes each time, remove excess PFA.
③为使细胞中原有的水分脱去,方便试剂进入和反应,在固定好的细胞上加入预冷的100%甲醇,立即放入-80℃孵育15分钟,进行组织脱水和变性。反应完成后,将样品从-80℃取出,置于室温平衡5分钟,然后将液体弃掉,室温下PBST洗3次,每次5分钟。③In order to remove the original water in the cells and facilitate the entry and reaction of reagents, pre-cooled 100% methanol was added to the fixed cells, and immediately incubated at -80°C for 15 minutes to dehydrate and denature the tissues. After the reaction was completed, the sample was taken out from -80°C, placed at room temperature for 5 minutes, and then the liquid was discarded, and washed 3 times with PBST at room temperature, 5 minutes each time.
④为了增加细胞通透性,让后续反应试剂中大分子试剂易于进入细胞,使用0.1M盐酸溶液透化细胞膜,使细胞膜上形成孔洞结构。该过程室温下处理细胞5分钟,反应完成后弃掉液体,室温下PBST洗3次,每次5分钟。④ In order to increase cell permeability and allow macromolecular reagents in subsequent reaction reagents to easily enter the cells, use 0.1M hydrochloric acid solution to permeabilize the cell membrane to form a hole structure on the cell membrane. In this process, the cells were treated at room temperature for 5 minutes, the liquid was discarded after the reaction was completed, and the cells were washed 3 times with PBST at room temperature, 5 minutes each time.
⑤细胞处理完成后,将含有锁式探针的杂交液加入到细胞样品上,探针的终浓度为100nM。37℃孵育过夜后,锁式探针结合到目标mRNA上,形成互补结构。反应完成后弃掉液体,室温下PBST洗3次,每次5分钟。⑤ After the cell treatment is completed, the hybridization solution containing the padlock probe is added to the cell sample, and the final concentration of the probe is 100nM. After overnight incubation at 37°C, the padlock probes bind to the target mRNA and form a complementary structure. Discard the liquid after the reaction is complete, wash with PBST 3 times at room temperature, 5 minutes each time.
4.连接反应4. Ligation reaction
锁式探针杂交到mRNA上后,需要将形成的缺口填补。这时,将含有4碱基随机片段的连接体系加入到反应腔室里,随机片段的终浓度为100nM。25℃孵育2个小时,在连接酶的作用下,与RNA互补配对的随机片段连接上半闭合锁式探针,形成完整的环状结构。反应完成后弃掉液体,室温下PBST洗3次,每次5分钟。After the padlock probe hybridizes to the mRNA, the gap formed needs to be filled. At this time, the ligation system containing 4-base random fragments was added into the reaction chamber, and the final concentration of the random fragments was 100 nM. Incubate at 25°C for 2 hours, under the action of ligase, the random fragments that are complementary to the RNA are connected to the semi-closed padlock probe to form a complete circular structure. Discard the liquid after the reaction is complete, wash with PBST 3 times at room temperature, 5 minutes each time.
5.滚环扩增5. Rolling Circle Amplification
锁式探针成环后,为了读取目标序列信息,要将捕获到的信息放大,此步骤采用滚环扩增的方式扩增锁式探针。配置含Phi29DNA聚合酶的滚环扩增体系,以RCA引发探针为引物,完成连接反应的半闭合锁式探针为模板,混匀后加入到反应腔室中,30℃孵育2小时。反应完成后弃掉液体,室温下PBST洗3次,每次5分钟。After the lock probe is formed into a circle, in order to read the target sequence information, the captured information must be amplified. This step uses rolling circle amplification to amplify the lock probe. Configure a rolling circle amplification system containing Phi29 DNA polymerase, use the RCA priming probe as a primer, and the half-closed locking probe that completes the ligation reaction as a template, mix well and add to the reaction chamber, and incubate at 30°C for 2 hours. Discard the liquid after the reaction is complete, wash with PBST 3 times at room temperature, 5 minutes each time.
6.原位测序(应用连接测序的原理)6. In situ sequencing (application of the principle of ligation sequencing)
①第一轮测序① The first round of sequencing
a.将含有锚定引物Anchor-1和4种测序引物的连接测序体系加入反应腔室中进行原位测序反应,25℃孵育2小时。锚定引物和测序引物的序列如表2所示。a. Add the ligation sequencing system containing anchor primer Anchor-1 and 4 kinds of sequencing primers into the reaction chamber for in situ sequencing reaction, and incubate at 25°C for 2 hours. The sequences of anchor primers and sequencing primers are shown in Table 2.
表2Table 2
反应完成后弃掉液体,室温下PBST洗3次,每次5分钟。加入0.1μg/mL的DAPI染细胞核,室温孵育5分钟。反应完成后弃掉液体,室温下PBST洗3次,每次5分钟。Discard the liquid after the reaction is complete, wash with PBST 3 times at room temperature, 5 minutes each time. Add 0.1 μg/mL DAPI to stain cell nuclei and incubate at room temperature for 5 minutes. Discard the liquid after the reaction is complete, wash with PBST 3 times at room temperature, 5 minutes each time.
b.应用Leica TCS SP8激光共聚焦进行成像,对待测的第一位碱基进行测序结果读取,同时解读目标mRNA的数量、空间位置及序列信息。设置好不同荧光对应的通道,观察并设置细胞信号的范围,以0.4μm的步径对样品进行层扫,然后叠加各层图像获得整体信号的图像。b. Apply Leica TCS SP8 laser confocal imaging, read the sequencing result of the first base to be tested, and interpret the quantity, spatial position and sequence information of the target mRNA at the same time. Set the channels corresponding to different fluorescence, observe and set the range of cell signal, scan the sample with a step of 0.4 μm, and then superimpose the images of each layer to obtain the image of the overall signal.
②第二轮测序②The second round of sequencing
a.配置70%甲酰胺洗脱缓冲液,加入至反应腔室中,室温孵育5分钟,将第一轮的测序信号洗脱掉。反应完成后弃掉液体,室温下PBST洗3次,每次5分钟。a. Prepare 70% formamide elution buffer, add it to the reaction chamber, and incubate at room temperature for 5 minutes to elute the first-round sequencing signal. Discard the liquid after the reaction is complete, wash with PBST 3 times at room temperature, 5 minutes each time.
b.将含有锚定引物Anchor-2和4种测序引物的连接测序体系加入反应腔室中,按照第一轮测序的反应时间及流程,对待测的第二位碱基进行测序结果读取。第二轮成像时,必须保持与第一次成像时相同的位置及参数。b. Add the ligation sequencing system containing the anchor primer Anchor-2 and 4 kinds of sequencing primers into the reaction chamber, and read the sequencing results of the second base to be tested according to the reaction time and process of the first round of sequencing. In the second round of imaging, the same position and parameters as the first imaging must be maintained.
③第三轮测序③ The third round of sequencing
a.配置70%甲酰胺洗脱缓冲液,加入至反应腔室中,室温孵育5分钟,将第二轮的测序信号洗脱掉。反应完成后弃掉液体,室温下PBST洗3次,每次5分钟。a. Prepare 70% formamide elution buffer, add it to the reaction chamber, and incubate at room temperature for 5 minutes to elute the second-round sequencing signal. Discard the liquid after the reaction is complete, wash with PBST 3 times at room temperature, 5 minutes each time.
b.将含有锚定引物Anchor-3和4种测序引物的连接测序体系加入反应腔室中,按照第一轮测序的反应时间及流程,对待测的第三位碱基进行测序结果读取。第三轮成像时,必须保持成像时相同的位置及参数。b. Add the ligation sequencing system containing the anchor primer Anchor-3 and 4 kinds of sequencing primers into the reaction chamber, and read the sequencing results of the third base to be tested according to the reaction time and process of the first round of sequencing. In the third round of imaging, the same position and parameters during imaging must be maintained.
③第四轮测序③ The fourth round of sequencing
a.配置70%甲酰胺洗脱缓冲液,加入至反应腔室中,室温孵育5分钟,将第三轮的测序信号洗脱掉。反应完成后弃掉液体,室温下PBST洗3次,每次5分钟。a. Prepare 70% formamide elution buffer, add it to the reaction chamber, and incubate at room temperature for 5 minutes to elute the sequencing signal of the third round. Discard the liquid after the reaction is complete, wash with PBST 3 times at room temperature, 5 minutes each time.
b.将含有锚定引物Anchor-4和4种测序引物的连接测序体系加入反应腔室中,按照第一轮测序的反应时间及流程,对待测的第四位碱基进行测序结果读取。第四轮成像时,必须保持成像时相同的位置及参数。b. Add the ligation sequencing system containing anchor primer Anchor-4 and 4 kinds of sequencing primers into the reaction chamber, and read the sequencing results of the fourth base to be tested according to the reaction time and process of the first round of sequencing. In the fourth round of imaging, the same position and parameters during imaging must be maintained.
7.数据分析7. Data analysis
对上述获得的四轮测序信息进行匹配,解读出锁式探针形成的Gap中捕获的mRNA序列。The four rounds of sequencing information obtained above were matched, and the mRNA sequence captured in the Gap formed by the padlock probe was read out.
如图4所示:靶序列位于β-Actin基因转录的mRNA上,待测部分为其上一段4个碱基长的序列,根据已有资料,序列为5’-GGCC-3’。试验过程中,使用的测序探针发出不同的荧光颜色,分别对应着测序到了不同的碱基。其对应关系如下:绿色——测序到A(腺嘌呤);红色——测序到C(胞嘧啶);品红色——测序到T(胸腺嘧啶);靛青色——测序到G(鸟嘌呤)。从待测序列5’端向3’端依次测序,根据我们的实验结果,得到的图像颜色为:红色-红色-靛青色-靛青色,即对应测序的结果为:5’-GGCC-3’,与预期完全相符。As shown in Figure 4: the target sequence is located on the mRNA transcribed by the β-Actin gene, and the part to be tested is a sequence of 4 bases long on it. According to the existing data, the sequence is 5'-GGCC-3'. During the experiment, the sequencing probes used emit different fluorescent colors, corresponding to different bases sequenced. The corresponding relationship is as follows: green - sequenced to A (adenine); red - sequenced to C (cytosine); magenta - sequenced to T (thymine); indigo - sequenced to G (guanine) . Sequencing from the 5' end to the 3' end of the sequence to be tested, according to our experimental results, the color of the image obtained is: red-red-indigo-indigo, that is, the corresponding sequencing result is: 5'-GGCC-3' , exactly as expected.
其它未详细说明的部分均为现有技术。尽管上述实施例对本发明做出了详尽的描述,但它仅仅是本发明一部分实施例,而不是全部实施例,人们还可以根据本实施例在不经创造性前提下获得其他实施例,这些实施例都属于本发明保护范围。Other parts not specified in detail are all prior art. Although the foregoing embodiment has described the present invention in detail, it is only a part of the embodiments of the present invention, rather than all embodiments, and people can also obtain other embodiments according to the present embodiment without inventive step, these embodiments All belong to the protection scope of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310290116.2A CN116445594A (en) | 2023-03-23 | 2023-03-23 | Sequencing method suitable for in-situ detection of continuous multiple nucleotide sites and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310290116.2A CN116445594A (en) | 2023-03-23 | 2023-03-23 | Sequencing method suitable for in-situ detection of continuous multiple nucleotide sites and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116445594A true CN116445594A (en) | 2023-07-18 |
Family
ID=87121161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310290116.2A Pending CN116445594A (en) | 2023-03-23 | 2023-03-23 | Sequencing method suitable for in-situ detection of continuous multiple nucleotide sites and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116445594A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117343993A (en) * | 2023-12-01 | 2024-01-05 | 中国科学院遗传与发育生物学研究所 | Methods for in situ detection of target nucleic acid sequences in samples |
-
2023
- 2023-03-23 CN CN202310290116.2A patent/CN116445594A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117343993A (en) * | 2023-12-01 | 2024-01-05 | 中国科学院遗传与发育生物学研究所 | Methods for in situ detection of target nucleic acid sequences in samples |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6571895B1 (en) | Nucleic acid probe and genomic fragment detection method | |
US20220042090A1 (en) | PROGRAMMABLE RNA-TEMPLATED SEQUENCING BY LIGATION (rSBL) | |
KR102307230B1 (en) | Multiplex detection of nucleic acids | |
CN105358709B (en) | System and method for detecting genome copy numbers variation | |
CN1703521B (en) | Quantification of gene expression | |
KR102592367B1 (en) | Systems and methods for clonal replication and amplification of nucleic acid molecules for genomic and therapeutic applications | |
KR20190034164A (en) | Single cell whole genomic libraries and combinatorial indexing methods for their production | |
CN109468384B (en) | Composite amplification detection kit for simultaneously detecting 45Y loci | |
CN111154754B (en) | Probe set for analyzing DNA sample and method for using the same | |
US20150191781A1 (en) | Random-primed transcriptase in-vitro transcription method for rna amplification | |
US20070172841A1 (en) | Probe/target stabilization with add-in oligo | |
CN108463559A (en) | The deep sequencing profile analysis of tumour | |
CN109536577B (en) | A kind of assay method and application of terminal deoxynuclease activity | |
CN115109842A (en) | High sensitivity method for accurate parallel quantification of nucleic acids | |
CN116445594A (en) | Sequencing method suitable for in-situ detection of continuous multiple nucleotide sites and application thereof | |
CN112903641A (en) | Biosensor for detecting histone modification enzyme and detection method and application thereof | |
KR20240032630A (en) | Methods for accurate parallel detection and quantification of nucleic acids | |
CN114480582A (en) | Method for decomposing and sparsely reading high-density signals in space omics and application thereof | |
CN114350773A (en) | A method for DNA molecular signal amplification and nucleic acid sequencing based on solid-phase carrier | |
US20070099193A1 (en) | Probe/target stabilization with add-in oligo | |
US20250188530A1 (en) | Method of detection of a target nucleic acid sequence in a single reaction vessel | |
CN119193827A (en) | A microRNA fluorescent biosensor for quantitative detection of colorectal cancer and its preparation method and application | |
KR20240032631A (en) | Highly sensitive methods for accurate parallel quantification of variant nucleic acids | |
WO2024259301A1 (en) | Methods for specific detection of nucleic acid sequences using in vitro transcription and in situ sequencing | |
HK40072445A (en) | Highly sensitive methods for accurate parallel quantification of nucleic acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |